Literature DB >> 27012474

MicroRNA-141 is upregulated in preeclamptic placentae and regulates trophoblast invasion and intercellular communication.

Stephanie Ospina-Prieto1, Wittaya Chaiwangyen2, Jörg Herrmann3, Tanja Groten1, Ekkehard Schleussner1, Udo R Markert4, Diana M Morales-Prieto5.   

Abstract

Preeclampsia (PE) is one of the leading causes of maternal and perinatal morbidity and mortality worldwide. Abnormal expression of microRNAs (miRNAs) occurs in several pregnancy diseases including PE. Placental trophoblast cells express a specific set of miRNAs which changes during pregnancy. These miRNAs can be released within extracellular vesicles (EVs) and mediate intercellular communication. miR-141 is a pregnancy-related miRNA which is expressed by trophoblast cells at increased levels in maternal plasma in the third trimester. We hypothesize that miR-141 is abnormally expressed in PE placentae, controls trophoblast, and immune cell functions and is involved in the intercellular communication between fetal trophoblast and maternal immune cells. Expression of miR-141 was analyzed by quantitative real-time PCR (qPCR) in normal and preeclamptic placentae and in 2 different trophoblastic cell lines, JEG-3 and HTR-8/SVneo. Changes in JEG-3 and HTR-8/SVneo cell proliferation and invasion were investigated after miR-141 inhibition and overexpression by MTS-, BrdU-, and Matrigel assays. EVs from miR-141 transfected cells were isolated from supernatants and characterized by NanoSight analysis and qPCR. Proliferation of Jurkat T cells and invasion of HTR-8/SVneo cells were investigated after treatment with EVs containing different miR-141 levels. miR-141 expression was higher in placentae from PE patients compared with those from normal pregnancies. miR-141 inhibition in trophoblastic cells resulted in decreased cell viability and reduced invasion capability. After transfection with miR-141-mimic, trophoblastic cells secreted EVs with increased miR-141 content. These vesicles did not exert effects on trophoblastic cell invasion but reduced Jurkat T cell proliferation. In conclusion, miR-141 regulates major functions of trophoblastic and immune cells. Trophoblast cells release EVs whose miRNA content can be modified by transfection of origin cells. Furthermore, elevated levels of miR-141 can be transferred from trophoblast to immune cells by release and internalization of EVs suggesting their role in the immune regulation of normal and pathologic pregnancies.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27012474     DOI: 10.1016/j.trsl.2016.02.012

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  39 in total

1.  Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression.

Authors:  Thomas J Rogers; Jessica L Christenson; Lisa I Greene; Kathleen I O'Neill; Michelle M Williams; Michael A Gordon; Travis Nemkov; Angelo D'Alessandro; Greg D Degala; Jimin Shin; Aik-Choon Tan; Diana M Cittelly; James R Lambert; Jennifer K Richer
Journal:  Mol Cancer Res       Date:  2018-09-13       Impact factor: 5.852

Review 2.  The Role of Progesterone in Feto-Maternal Immunological Cross Talk.

Authors:  Julia Szekeres-Bartho
Journal:  Med Princ Pract       Date:  2018-06-27       Impact factor: 1.927

3.  miR-335 targets CRIM1 to promote the proliferation and inhibit the apoptosis of placental trophoblast cells in preeclamptic rats.

Authors:  Liuyan Jiang; Meiyan Li; Haisi Gan; Li Yang; Fengjuan Lin; Min Hu
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

Review 4.  The function of miR-519d in cell migration, invasion, and proliferation suggests a role in early placentation.

Authors:  Lan Xie; Yoel Sadovsky
Journal:  Placenta       Date:  2016-10-10       Impact factor: 3.481

Review 5.  Extracellular vesicles and their immunomodulatory functions in pregnancy.

Authors:  Soumyalekshmi Nair; Carlos Salomon
Journal:  Semin Immunopathol       Date:  2018-04-03       Impact factor: 9.623

Review 6.  Embryonic extracellular vesicles as informers to the immune cells at the maternal-fetal interface.

Authors:  E Giacomini; E Alleva; G Fornelli; A Quartucci; L Privitera; V S Vanni; P Viganò
Journal:  Clin Exp Immunol       Date:  2019-05-06       Impact factor: 4.330

Review 7.  Placental extracellular vesicles and pre-eclampsia.

Authors:  Jessica Schuster; Shi-Bin Cheng; James Padbury; Surendra Sharma
Journal:  Am J Reprod Immunol       Date:  2020-07-18       Impact factor: 3.886

Review 8.  Extracellular Vesicles and Antiphospholipid Syndrome: State-of-the-Art and Future Challenges.

Authors:  Ula Štok; Saša Čučnik; Snežna Sodin-Šemrl; Polona Žigon
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

Review 9.  MicroRNA-mRNA Networks in Pregnancy Complications: A Comprehensive Downstream Analysis of Potential Biomarkers.

Authors:  Asghar Ali; Frieder Hadlich; Muhammad W Abbas; Muhammad A Iqbal; Dawit Tesfaye; Gerrit J Bouma; Quinton A Winger; Siriluck Ponsuksili
Journal:  Int J Mol Sci       Date:  2021-02-25       Impact factor: 5.923

Review 10.  Roles of noncoding RNAs in preeclampsia.

Authors:  Ningxia Sun; Shiting Qin; Lu Zhang; Shiguo Liu
Journal:  Reprod Biol Endocrinol       Date:  2021-07-02       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.